The polymorphisms in Toll-like receptor genes and cancer risk

Periodicum Biologorum

Volumn 114, Issue 4, 2012, Pages 461-469

  Gomaz, Ana ^a   Pavelić, Jasminka ^a   Matijević Glavan, Tanja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Cancer; Immune response; Inflammation; Polymorphism; Toll like receptor

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; PACLITAXEL; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER RISK; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INNATE IMMUNITY; LYMPHOID TISSUE; METASTASIS; MICROENVIRONMENT; NEOPLASM; PROTEIN LOCALIZATION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84877872421     PISSN: 00315362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. ROCK F L, HARDIMAN G, TIMANS J C, KASTELEIN R A, BAZANJ F 1998 A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 95: 588-593
2. KAWAI T, AKIRA S 2010 The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384
3. ANDERSON K V, JÜRGENS G, NÜSSLEIN-VOLHARD C 1985 Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 42: 779-789
4. ARMANTMA, FENTONMJ 2002 Toll-like receptors: a family of pattern recognition receptors in mammals. Genome Biol 3: reviews 3011.1-reviews 3011.6
5. MEDZHITOV R, PRESTONHURLBURT P, JANEWAY C A JR 1997 A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397
6. HUYTON T, ROSSJOHN J, WILCE M 2007 Toll-like receptors: structural pieces of a curve-shaped puzzle. Immunol Cell Biol 85: 406-410
7. YAMAMOTO M, TAKEDA K, AKIRA S 2004 TIR domain-containing adaptors define the specificity of TLR signaling. Mol Immunol 40: 861-868
8. MATIJEVIC T, MARJANOVIC M, PAVELIC J 2009 Functionally active toll-like receptor 3 on human primary and metastatic cancer cells. Scand J Immunol 70: 18-24
9. YU L, CHEN S 2008 Toll-like receptors expressed in tumor cells: targets for therapy. Cancer Immunol Immunother 57: 1271-1278
10. HUANG B, ZHAO J, UNKELESS J C, FENG Z H, XIONG H 2008 TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27: 218-224
11. MATIJEVIC T, PAVELIC J 2010 Toll-like receptors: cost or benefit for cancer? Curr Pharm Des 16: 1081-1090
12. MATIJEVIC T, KIRINEC G, PAVELIC J 2011 Antitumor activity fromthe combined application of poly(I:C) and chemotherapeutics in human metastatic pharyngeal cell lines. Chemotherapy 57: 460-467
13. GRIVENNIKOV S I, GRETEN F R, KARIN M 2010 Immunity, inflamation, and cancer. Cell 140: 883-899
14. SCHMAUSSER B, ANDRULIS M, ENDRICH S, MÜLLER--HERMELINKHK, ECKM2005Toll-like receptorsTLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 295: 179-185
15. HE W, LIU Q, WANG L, CHEN W, LI N, CAO X 2007 TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44: 2850-2859
16. YANGH, ZHOUH, FENGP, ZHOUX, WENH, XIEX, SHEN H, ZHU X 2010 Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J Exp Clin Cancer Res 29: 92
17. SZAJNIK M, SZCZEPANSKI M J, CZYSTOWSKA M, ELISHAEV E, MANDAPATHIL M, NOWAK-MARKWITZ E, SPACZYNSKIM, WHITESIDE T L 2009 TLR4 signaling induced by lipopolysacharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Oncogene 28: 4353-4363
18. NIHON-YANAGI Y, TERAI K, MURANO T, MATSUMOTO T, OKAZUMI S 2012Tissue expression ofToll-like receptors 2 and 4 in sporadic human colorectal cancer. Cancer Immunol Immunother 61: 71-77
19. ALLALI-HASSANI A, WASNEY G A, CHAU I, HONG B S, SENISTERRAG, LOPPNAUP, SHI Z, MOULT J, EDWARDS A M, ARROWSMITHCH, PARKHW, SCHAPIRAM, VEDADIM 2009 A survey of proteins encoded by non-synonymous single nucleotide polymorphisms reveals a significant fraction with altered stability and activity. Biochem J 424: 15-26
20. JOHNSON C M, LYLE E A, OMUETI K O, STEPENSKY V A, YEGINO, ALPSOY E, HAMANNL, SCHUMANNR R, TAPPING R I 2007 Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178: 7520-7524
21. ETOKEBE G E, SKJELDAL F, NILSEN N, RODIONOV D, KNEZEVIC J, BULAT-KARDUM L, ESPEVIK T, BAKKE O, DEMBIC Z 2010 Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele. Scand J Immunol 71: 369-381
22. TAKEDA K, KAISHO T, AKIRA S 2003 Toll-like receptors. Annu Rev Immunol 21: 335-376
23. SUN J, WIKLUND F, ZHENG S L, CHANG B, BÄLTER K, LI L, JOHANSSON J E, LI G, ADAMI H O, LIU W, TOLIN A, TURNER A R, MEYERS D A, ISAACSWB, XU J, GRÖNBERG H 2005 Sequence variants in Toll-like receptor gene cluster (TLR6--TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst 97: 525-532
24. CHENY C, GIOVANNUCCI E, KRAFT P, LAZARUS R, HUNTER D J 2007 Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Cancer Epidemiol Biomarkers Prev 16: 1982-1989
25. STEVENS V L, HSINGAW, TALBOT J T, ZHENGS L, SUNJ, CHEN J, THUN M J, XU J, CALLE E E, RODRIGUEZ C 2008 Genetic variation in the toll-like receptor gene cluster (TLR10--TLR1-TLR6) and prostate cancer risk. Int J Cancer 123: 2644-2650
26. LINDSTRÖM S, HUNTER D J, GRÖNBERG H, STATTIN P, WIKLUND F, XU J, CHANOCK S J, HAYES R, KRAFT P 2010 Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis fromthree independent studies. Cancer Epidemiol Biomarkers Prev 19: 873-876
27. CERHAN J R, ANSELL S M, FREDERICKSEN Z S, KAY N E, LIEBOW M, CALL T G, DOGAN A, CUNNINGHAM J M, WANG AH, LIU-MARESW, MACONWR, JELINEK D, WITZIG T E, HABERMANN T M, SLAGER S L 2007 Genetic variation in 1253 immune and inflammation genes and risk of non--Hodgkin lymphoma. Blood 110: 4455-4463
28. PURDUE M P, LAN Q, WANG S S, KRICKER A, MENASHE I, ZHENG T Z, HARTGE P, GRULICH A E, ZHANG Y, MORTON L M, VAJDIC C M, HOLFORD T R, SEVERSON R K, LEADERER B P, CERHAN J R, YEAGER M, COZEN W, JACOBS K, DAVIS S, ROTHMAN N, CHANOCK S J, CHATTERJEE N, ARMSTRONG B K 2009 A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 30: 275-281
29. RAJARAMANP, BRENNER A V, NETAG, PFEIFFER R, WANG S S, YEAGERM, THOMAS G, FINEHA, LINETMS, ROTHMAN N, CHANOCK S J, INSKIP P D 2010 Risk of meningioma and common variation in genes related to innate immunity. Cancer Epidemiol Biomarkers Prev 19: 1356-1361
30. BARNHOLTZ-SLOANJ S, SHETTY PB, GUANX, NYANTES J, LUOJ, BRENNANDJ, MILLIKANR C2010 FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis 31: 1417-1423
31. TAHARA T, ARISAWA T, WANG F, SHIBATA T, NAKAMURA M, SAKATAM, HIRATA I, NAKANO H 2007 Toll-like receptor 2-196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci 98: 1790-1794
32. HISHIDA A, MATSUO K, GOTO Y, NAITO M, WAKAI K, TAJIMAK, HAMAJIMAN2010No associations of Toll-like receptor 2 (TLR2)-196 to-174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese. Gastric Cancer 13: 251-257
33. ZENGHM, PANK F, ZHANGY, ZHANGL, MA J L, ZHOUT, SU H J, LIWQ, LI J Y, GERHARDM, CLASSENM, YOUWC 2011Genetic variants of toll-like receptor 2 and 5, Helicobacter pylori infection, and risk of gastric cancer and its precursors in a Chinese population. Cancer Epidemiol Biomarkers Prev 20: 2594-2602
34. DE OLIVEIRA J G, SILVA A E 2012 Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in Brazilian population. World J Gastroenterol 18: 1235-1242
35. NISCHALKE H.-D, COENENM, BERGER C, ALDENHOFF K, MÜLLER T, BERG T, KRÄMER B, KÖRNER C, ODENTHAL M, SCHULZE F, GRÜNHAGE F, NATTERMANN J, SAUERBRUCH T, SPENGLER U 2012 The toll-like receptor 2 (TLR2)-196 to-174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. Int J Cancer 130: 1470-1475
36. THEODOROPOULOS G E, SARIDAKIS V, KARANTANOS T, MICHALOPOULOS N V, ZAGOURI F, KONTOGIANNI P, LYMPERI M, GAZOULI M, ZOGRAFOS G C 2012 Toll-like receptors gene polymorphismsmay confer increased susceptibility to breast cancer development. Breast 21: 534-538
37. MANDAL R K, GEORGE G P, MITTAL R D 2012 Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population. Mol Biol Rep 39: 7263-7269
38. SRIVASTAVA K, SRIVASTAVA A, KUMAR A, MITTAL B 2011 Gallbladder cancer predisposition: a multigenic approach to DNA--repair, apoptotic and inflammatory pathway genes. PLoS ONE 6: e16449
39. PANDEY S, MITTAL R D, SRIVASTAVA M, SRIVASTAVA K, SINGH S, SRIVASTAVA S, MITTAL B 2009 Impact of Toll-like receptors [TLR] 2 (-196 to-174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility inNorth Indian women. Gynecol Oncol 114: 501-505
40. BORASKA JELAVIC T, BARISIC M, DRMIC HOFMAN I, BORASKA V, VRDOLJAK E, PERUZOVICM, HOZOI, PULJIZ Z, TERZIC J 2006 Microsatelite GT polymorphism in the toll-like receptor 2 is associatedwith colorectal cancer. ClinGenet 70: 156-160
41. JUNJIE X, SONGYAO J, MINMIN S, YANYAN S, BAIYONG S, XIAXING D, JIABIN J, XI Z, HAO C 2012 The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility. BMC Cancer 12: 57
42. ETOKEBE G E, KNEZEVIC J, PETRICEVIC B, PAVELIC J, VRBANECD, DEMBIC Z 2009 Single-nucleotide polymorphisms in genes encoding toll-like receptor-2,-3,-4, and-9 in case-control study with breast cancer. Genet Test Mol Biomarkers 13: 729-734
43. HE J-F, JIA W-H, FAN Q, ZHOU X-X, QIN H-D, SHUGART Y-Y, ZENG Y-X 2007 Genetic polymorphisms of TLR3 are associated with nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 7: 194
44. CASTROF A, FÖRSTI A, BUCHS, KALTHOFFH, KRAUSSC, BAUER M, EGBERTS J, SCHNIEWIND B, BROERING D C, SCHREIBER S, SCHMITT M, HAMPE J, HEMMINKI K, SCHAFMAYER C 2011 TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. Eur J Cancer 47: 1203-1210
45. HOLD G L, RABKIN C S, CHOW W H, SMITH M G, GAMMONM D, RISCH H A, VAUGHAN T L, MCCOLL K E, LISSOWSKA J, ZATONSKIW, SCHOENBERGJ B, BLOTWJ, MOWAT N A, FRAUMENI J F JR, EL-OMAR E M 2007 A functional polymorphismof toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132: 905-912
46. JING J J, LI M, YUAN Y 2012 Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis. Gene 499: 237-242
47. NIETERS A, BECKMANN L, DEEG E, BECKER N 2006 Gene polymorphisms inToll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun 7: 615-624
48. GAST A, BERMEJO J L, CLAUS R, BRANDT A, WEIRES M, WEBER A, PLASS C, SUCKER A, HEMMINKI K, SCHADENDORF D, KUMAR R 2011 Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival. PLoS ONE 6: e24370
49. YANG Z H, DAI Q, GU Y J, GUO Q X, GONG L 2012 Cytokine and chemokinemodification by Toll-like receptor polymorphisms is associatedwith nasopharyngeal carcinoma. Cancer Sci 103: 653-658
50. SONG C, CHEN L Z, ZHANG R H, YU X J, ZENG YX 2006 Functional variant in the 3'-untranslated region of Toll-like receptor 4 is associatedwith nasopharyngeal carcinoma risk. Cancer Biol Ther 5: 1285-1291
51. SONG J, KIMD Y, KIMC S, KIMHJ, LEE DH, LEEHM, KO W, LEEG2009The association betweenToll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men. Cancer Genet Cytogenet 190: 88-92
52. HUANGH, WU J, JING, ZHANGH, DING Y, HUA Z, ZHOU Y, XUE Y, LU Y, HU Z, XU Y, SHEN H 2010 A 5'-flanking region polymorphismin toll-like receptor 4 is associated with gastric cancer in a Chinese population. J Biomed Res 24: 100-106
53. KNEZEVIC J, PAVLINIC D, ROSE W A 2ND, LEIFER C A, BENDELJA K, GABRILOVAC J, PARCINAM, LAUCG, KUBARENKOAV, PETRICEVICB, VRBANECD, BULAT-KARDUM L, BEKEREDJIAN-DINGI, PAVELICJ, DEMBICZ, WEBER A N2012Heterozygous carriage of a dysfunctionalToll-like receptor 9 allele affects CpG oligonucleotide responses in B cells. J Biol Chem 287: 24544-24553
54. MOLLAKI V, GEORGIADIS T, TASSIDOU A, IOANNOU M, DANIILZ, KOUTSOKERA A, PAPATHANASSIOUA A, ZINTZARAS E, VASSILOPOULOS G 2009 Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study. J Hum Genet 54: 655-659
55. ROSZAK A, LIANERI M, SOWIÑSKA A, JAGODZIÑSKI P P 2012 Involvement of toll-like receptor 9 polymorphism in cervical cancer development. Mol Biol Rep 39: 8425-8430